1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SIRT2 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA ZNF146 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA FAM83F CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA BSN CTRPv2 pan-cancer AAC 0.21 3e-07
mRNA FES CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA RNF144A CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA PHF2 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA LKAAEAR1 CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA UNC79 CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA TNFAIP8L2 CTRPv2 pan-cancer AAC 0.21 4e-07
Download CSV